Galectin-9 Significantly Prolongs the Survival of Fully Mismatched Cardiac Allografts in Mice

Abstract

A short-course administration of galectin-9 significantly prolonged the survival of fully allogeneic cardiac allografts, which was associated with the suppression of Th1 and Th17 immune responses.